GALECTIN THERAPEUTICS INC Business Finance Contracts & Agreements
77 Contracts & Agreements
- Credit Agreements (4 contracts)
- Escrow Agreements (1)
- Exchange Agreements (1)
- Loan Agreements (1)
- Modification Agreements (1)
- Note Agreements (5)
- Purchase Agreements (10)
- Registration Rights Agreements (8)
- Security Agreements (1)
- Share Agreements (1)
- Stock Agreements (11)
- Subscription Agreements (5)
- Underwriting Agreements (1)
- Warrant Agreements (27)
- 2020 Deferred Stock Unit Amendment (Filed With SEC on July 26, 2022)
- 2023 Deferred Stock Unit Agreement (Filed With SEC on July 26, 2022)
- Form of Convertible Promissory Note (Filed With SEC on July 26, 2022)
- Line of Credit Letter Agreement, dated as of July 25, 2022, by and between Richard E. Uihlein and the Company (Filed With SEC on July 26, 2022)
- Form of Warrant (Filed With SEC on July 26, 2022)
- Unsecured Convertible Promissory Note, dated December 20, 2021 (Filed With SEC on December 21, 2021)
- Unsecured Convertible Promissory Note, dated September 17, 2021 (Filed With SEC on September 21, 2021)
- Loan Agreement, dated September 17, 2021 (Filed With SEC on September 21, 2021)
- Convertible Promissory Note, dated April 16, 2021 (Filed With SEC on April 19, 2021)
- Deferred Stock Unit Agreement, dated August 31, 2020, between Galectin Therapeutics Inc. and Joel Lewis (Filed With SEC on September 2, 2020)
- Second Amendment to Line of Credit Letter Agreement, dated January 11, 2019, by and between Richard E. Uihlein and the Company (Filed With SEC on January 15, 2019)
- Form of Amended and Restated 10X Fund Class B Common Stock Purchase Warrant (Filed With SEC on January 15, 2019)
- Form of Amended and Restated Class B Common Stock Purchase Warrant (Filed With SEC on January 15, 2019)
- Second Amendment to Common Stock Purchase Warrant, dated January 11, 2019, by and between Richard E. Uihlein and the Company (Filed With SEC on January 15, 2019)
- First Amendment to Line of Credit Agreement, dated as of December 20, 2018, by and between Richard E. Uihlein and the Company (Filed With SEC on January 3, 2019)
- First Amendment to Common Stock Purchase Warrant, dated December 20, 2018, by and between Richard E. Uihlein and the Company (Filed With SEC on January 3, 2019)
- Line of Credit Agreement, dated as of December 19, 2017, by and between Richard E. Uihlein and the Company (Filed With SEC on December 19, 2017)
- Form of Common Stock Purchase Warrant (Filed With SEC on December 19, 2017)
- GALECTIN THERAPEUTICS INC. Common Stock (par value $0.001per share) At Market Issuance Sales Agreement (Filed With SEC on May 19, 2017)
- SECOND AMENDMENT TOSECURITIES PURCHASE AGREEMENT (Filed With SEC on December 29, 2016)
- GALECTIN THERAPEUTICS, INC. SUBSCRIPTION AGREEMENT (Filed With SEC on December 29, 2016)
- GALECTIN THERAPEUTICS, INC. COMMON STOCK PURCHASE WARRANT (Filed With SEC on December 29, 2016)
- REGISTRATION RIGHTS AGREEMENT (Filed With SEC on September 27, 2016)
- SECURITIES PURCHASE AGREEMENT (Filed With SEC on September 27, 2016)
- GALECTIN THERAPEUTICS, INC. COMMON STOCK PURCHASE WARRANT CLASS B-3 (Filed With SEC on September 27, 2016)
- GALECTIN THERAPEUTICS, INC. COMMON STOCK PURCHASE WARRANT CLASS B-3 (Filed With SEC on September 27, 2016)
- PROJECT ADDENDUM MODIFICATION (Filed With SEC on March 15, 2016)
- REGISTRATION RIGHTS AGREEMENT (Filed With SEC on November 20, 2015)
- SECURITIES PURCHASE AGREEMENT (Filed With SEC on November 20, 2015)
- COMMON STOCK PURCHASE WARRANT GALECTIN THERAPEUTICS, INC. (Filed With SEC on November 20, 2015)
- GALECTIN THERAPEUTICS INC. Common Stock (par value $0.001per share) At Market Issuance Sales Agreement (Filed With SEC on October 25, 2013)
- STOCK OPTION AGREEMENT GALECTIN THERAPEUTICS INC. STOCK OPTION AGREEMENT FOR THOMAS MCGAULEY AGREEMENT (Filed With SEC on August 14, 2013)
- GALECTIN THERAPEUTICS INC. COMMON STOCK PURCHASE WARRANT CLASS B (Filed With SEC on August 14, 2013)
- GALECTIN THERAPEUTICS INC. COMMON STOCK PURCHASE WARRANT CLASS A-2 (Filed With SEC on August 14, 2013)
- GALECTIN THERAPEUTICS INC. FORM OF WARRANT AGREEMENT (Filed With SEC on March 23, 2012)
- $10,435,005 of Units GALECTIN THERAPEUTICS INC. Units Consisting of Two Shares of Common Stock and One Warrant to Purchase One Share of Common Stock UNDERWRITING AGREEMENT (Filed With SEC on March 23, 2012)
- PRO-PHARMACEUTICALS, INC. NON-QUALIFIED STOCK OPTION AGREEMENT FOR PETER G. TRABER, M.D. (Filed With SEC on March 9, 2011)
- PRO-PHARMACEUTICALS, INC. COMMON STOCK PURCHASE WARRANT CLASS B-1 (Filed With SEC on January 27, 2011)
- PRO-PHARMACEUTICALS, INC. COMMON STOCK PURCHASE WARRANT CLASS A-2 (Filed With SEC on January 27, 2011)
- PRO-PHARMACEUTICALS, INC. COMMON STOCK PURCHASE WARRANT CLASS A-1 (Filed With SEC on January 27, 2011)
